Influence of Coronary Calcification on the Diagnostic Performance of CT Angiography Derived FFR in Coronary Artery Disease A Substudy of the NXT Trial by Nørgaard, Bjarne L. et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 8 , N O . 9 , 2 0 1 5
ª 2 0 1 5 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 5 . 0 6 . 0 0 3Inﬂuence of Coronary Calciﬁcation
on the Diagnostic Performance of
CT Angiography Derived FFR in
Coronary Artery Disease
A Substudy of the NXT TrialBjarne L. Nørgaard, MD, PHD,* Sara Gaur, MD,* Jonathon Leipsic, MD, PHD,y Hiroshi Ito, MD, PHD,z
Toru Miyoshi, MD, PHD,z Seung-Jung Park, MD, PHD,x Ligita Zvaigzne, MD,k Nikolaos Tzemos, MD, PHD,{
Jesper M. Jensen, MD, PHD,* Nicolaj Hansson, MD,* Brian Ko, MBBS, PHD,# Hiram Bezerra, MD, PHD,**
Evald H. Christiansen, MD, PHD,* Anne Kaltoft, MD, PHD,* Jens F. Lassen, MD, PHD,* Hans Erik Bøtker, MD, DMSCI,*
Stephan Achenbach, MD, PHDyyABSTRACTOBJECTIVES The goal of this study was to examine the diagnostic performance of noninvasive fractional ﬂow reserve
(FFR) derived from coronary computed tomography angiography (CTA) (FFRCT) in relation to coronary calciﬁcation
severity.
BACKGROUND FFRCT has shown promising results in identifying lesion-speciﬁc ischemia. The extent to which the
severity of coronary calciﬁcation affects the diagnostic performance of FFRCT is not known.
METHODS Coronary calciﬁcation was assessed by using the Agatston score (AS) in 214 patients suspected
of having coronary artery disease who underwent coronary CTA, FFRCT, and FFR (FFR examination was
performed in 333 vessels). The diagnostic performance of FFRCT (#0.80) in identifying vessel-speciﬁc ischemia
(FFR #0.80) was investigated across AS quartiles (Q1 to Q4) and for discrimination of ischemia in patients
and vessels with a low-mid AS (Q1 to Q3) versus a high AS (Q4). Coronary CTA stenosis was deﬁned as lumen
reduction >50%.
RESULTS Mean  SD per-patient and per-vessel AS were 302  468 (range 0 to 3,599) and 95  172 (range 0 to
1,703), respectively. There was no statistical difference in diagnostic accuracy, sensitivity, or speciﬁcity of FFRCT across AS
quartiles. Discrimination of ischemia by FFRCT was high in patients with a high AS (416 to 3,599) and a low-mid AS (0 to
415), with no difference in area under the receiver-operating characteristic curve (AUC) (0.86 [95% conﬁdence interval
(CI): 0.76 to 0.96] vs. 0.92 [95% CI: 0.88 to 0.96]) (p ¼ 0.45). Similarly, discrimination of ischemia by FFRCT was high in
vessels with a high AS (121 to 1,703) and a low-mid AS (0 to 120) (AUC: 0.91 [95% CI: 0.85 to 0.97] vs. 0.95 [95% CI:
0.91 to 0.98]; p ¼ 0.65). Diagnostic accuracy and speciﬁcity of FFRCT were signiﬁcantly higher than for stenosis
assessment in each AS quartile at the per-patient (p < 0.001) and per-vessel (p < 0.05) level with similar sensitivity. In
vessels with a high AS, FFRCT exhibited improved discrimination of ischemia compared with coronary CTA alone (AUC:
0.91 vs. 0.71; p ¼ 0.004), whereas on a per-patient level, the difference did not reach statistical signiﬁcance (AUC: 0.86
vs. 0.72; p ¼ 0.09).
CONCLUSIONS FFRCT provided high and superior diagnostic performance compared with coronary CTA interpretation
alone in patients and vessels with a high AS. (J Am Coll Cardiol Img 2015;8:1045–55) © 2015 by the American College of
Cardiology Foundation.
ABBR EV I A T I ON S
AND ACRONYMS
AS = Agatston score
AUC = area under the receiver-
operating characteristic curve
CAD = coronary artery disease
CI = conﬁdence interval
CTA = computed tomography
angiography
FFR = fractional ﬂow reserve
FFRCT = fractional ﬂow reserve
derived from coronary
computed tomography
angiography
ICA = invasive coronary
angiography
NPV = negative predictive
value
PPV = positive predictive value
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1046N oninvasive anatomic assessmentby coronary computed tomographyangiography (CTA) shows high
diagnostic performance for the detection or
exclusion of coronary artery disease (CAD)
(1–8). However, coronary CTAhas onlymodest
accuracy regarding the quantiﬁcation of ste-
nosis severity, particularly in the setting of
coronary calciﬁcation. The presence of calci-
ﬁed coronary lesions often leads to overesti-
mation of stenosis severity due to blooming
and beam-hardening artifacts obscuring the
vessel lumen. Thus, the presence of coronary
calciﬁcation is associated with reduced diag-
nostic speciﬁcity of coronary CTA (1–8). More-
over, coronary CTA, in its current form, has
a limited capacity to determine the hemo-
dynamic signiﬁcance of coronary stenosis
(9–12). These ﬁndings have prompted concernthat the widespread utilization of coronary CTA may
result in an increase in unneeded downstream diag-
nostic and therapeutic procedures (13,14).SEE PAGE 1056Recent advances in computational ﬂuid dynamics
and individual image-based modeling permit calcu-
lation of coronary blood ﬂow and pressure from
standard acquired by coronary CTA datasets at rest
without the need for additional imaging or medica-
tion (10–12,15). This technique allows for noninva-
sive calculation of fractional ﬂow reserve derived
from coronary computed tomography angiography
(FFRCT), which assesses the ratio of ﬂow across a
stenosis to putative ﬂow in the absence of stenosis.
In 3 prospective trials of patients with known or
suspected CAD, FFRCT exhibited high and superior
diagnostic performance compared with stenosis
assessment by coronary CTA in identifying ischemia
as revealed by invasive measured fractional ﬂow
reserve (FFR) (10–12). Because calcium compromises
identiﬁcation of vessel boundary conditions for
physiological modeling, the diagnostic performanceDepartment of Cardiology, Aarhus University Hospital Skejby, Aa
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calciﬁcation. The extent to which the presence and
severity of coronary calciﬁcation affects the diag-
nostic performance of FFRCT is not known. Thus, the
goal of the present study was to examine the diag-
nostic performance of FFRCT in relation to the
severity of coronary calciﬁcation in patients who
were enrolled in the prospective NXT (Analysis of
Coronary Blood Flow Using CT Angiography: Next
Steps) study and for whom coronary calcium scores
were available.
METHODS
STUDY DESIGN AND PATIENTS. The rationale and
design of the NXT trial have been described previ-
ously (12,16). In brief, the study was a prospective,
multicenter trial designed to assess the diagnostic
performance of FFRCT versus stenosis severity as
assessed with coronary CTA in patients suspected of
CAD by using FFR as the reference standard. Patients
had coronary CTA performed <60 days before
scheduled, nonemergent, clinically indicated inva-
sive coronary angiography (ICA). Exclusion criteria
included previous coronary intervention or coronary
bypass surgery, suspected acute coronary syndrome,
previous myocardial infarction <30 days before cor-
onary CTA or between coronary CTA and ICA, and
contraindications to beta-blockers, nitroglycerin, or
adenosine.
The study protocol was approved at each of the 10
participating centers by the local institutional review
board. All study subjects provided written informed
consent.
CORONARY CTA ACQUISITION AND ANALYSIS. Coronary
CTA was performed with the use of $64 detector row
scanners (temporal resolution 75 to 175 ms) using
standard acquisition protocols in accordance with
societal recommendations (17). Coronary calcium
scores were assessed by local investigators (in 8 of 10
participating centers) according to the Agatston
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TABLE 1 Baseline Characteristics (N ¼ 214)
Age, yrs 64  10 (32–84)
Male 132 (62)
Diabetes 49 (23)
Hypertension 146 (68)
Hyperlipidemia 168 (79)
Current smoker 37 (17)
Updated Diamond-Forrester risk score 53
Intermediate (20%–80%) pre-test risk 161 (75)
Body mass index, kg/m2 25.4  3.8 (15–35)
CT acquisition heart rate, beats/min 63  10 (40–110)
Values are mean  SD (range), n (%), or %.
CT ¼ computed tomography.
TABLE 2 Patient and Vessel Characteristics According to
Coronary CTA, ICA, FFRCT, and FFR
Patients with coronary CTA stenosis >50% 158 (74)
Patients with intermediate range (30%–70%) stenosis 197 (92)
Patients with FFRCT #0.80 82 (38)
Vessels with FFRCT #0.80 80 (24)
Patients with ICA stenosis >50% 64 (30)
Patients with FFR #0.80 60 (28)
Vessels with FFR #0.80 60 (18)
Patients with FFR #0.80 in >1 vessel 13 (6)
Values are n (%). The per-patient analysis was performed in 214 patients and the
per-vessel analysis in 163 patients (333 vessels).
CTA ¼ computed tomography angiography; FFR ¼ fractional ﬂow reserve;
FFRCT ¼ fractional ﬂow reserve derived from coronary computed tomography
angiography; ICA ¼ invasive coronary angiography.
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1047calculated by using a weighted value assigned to the
highest density of calciﬁcation in a given coronary
artery multiplied by the area of calcium. The calciﬁ-
cation score in each vessel is summed to give the AS.
A prospective electrocardiogram-triggered scan ac-
quired at 55% to 65% of the RR interval with 3-mm
slice thickness was used for the nonenhanced acqui-
sitions. For the contrast-enhanced scans, prospective
triggering or retrospective gating was used for scan
acquisition. Oral or intravenous beta-blockers, or
both, were administered to achieve a heart rate #60
beats/min. Sublingual nitroglycerin was administered
in all patients. Data acquisition was performed with
100-kV tube voltage in patients #70 kg and 120 kV
in patients >70 kg. Experienced local investigators
assessed luminal diameter stenosis in each seg-
ment $2 mm in diameter by using an 18-segment
coronary model before ICA. Signiﬁcant stenosis was
deﬁned as lumen reduction >50% in a major epicar-
dial coronary artery segment $2 mm in diameter.
ICA AND FFR. Diagnostic ICA was performed in all
patients according to societal guidelines (19). Angio-
grams were transferred to the Angiography/FFR Core
Laboratory (Harrington Heart and Vascular Institute,
University Hospitals, Cleveland, Ohio) for blinded
quantitative angiography. An ICA stenosis >50% was
considered obstructive. An FFR measurement (Pres-
sure Wire, St. Jude Medical, St. Paul, Minnesota) was
performed during ICA in at least 1 vessel segment
$2 mm in diameter and lumen stenosis $30%.
Hyperemia was achieved by continuous intravenous
adenosine infusion (infusion rate 140 to 180 mg/kg
per min). Lesion-speciﬁc ischemia was deﬁned
according to an FFR #0.80.
FFR DERIVED FROM CTA. Integration of patient-
speciﬁc models of coronary anatomy and physiology
to 3-dimensional computational ﬂuid dynamic
models enable computation of coronary ﬂow and
pressure at each point in the coronary tree under
simulated adenosine-mediated hyperemic conditions
(12,15,16). FFRCT was calculated by dividing the mean
distal coronary pressure by the mean aortic pressure.
Lesion-speciﬁc ischemia was deﬁned according to an
FFRCT #0.80. Three-dimensional blood ﬂow simula-
tions in the coronary vasculature were performed at
HeartFlow Inc. (Redwood City, California) with the
use of updated propriety software (version 1.4) in a
blinded fashion, as described previously (12,16).
INTEGRATION OF CORONARY CTA AND FFR. The
Angiography/FFR Core Laboratory received a 3-
dimensional computer model of the coronary anat-
omy without FFRCT values from the Core Laboratory
(HeartFlow Inc.). The model indicated the vessellocations in which FFR was measured. The corre-
sponding FFRCT values were used for comparison
(12,16).
STATISTICAL ANALYSIS. The per-patient and per-
vessel diagnostic performance of FFRCT (#0.80) and
coronary CTA (lumen reduction >50%) for the diag-
nosis of vessel-speciﬁc ischemia (FFR #0.80) were
assessed according to accuracy, sensitivity, speci-
ﬁcity, positive predictive value (PPV), and negative
predictive value (NPV) across AS quartiles (Q1 to Q4)
and for discrimination of ischemia by using the area
under the receiver-operating characteristic curve
(AUC) in patients and vessels with a high AS (Q4)
versus a low-mid AS (Q1 to Q3). The pre-test likeli-
hood of CAD was determined by using the updated
Diamond-Forrester risk score algorithm (20,21). AUC
comparisons were performed on per-patient and
per-vessel levels by using the method of DeLong et al.
(22). Diagnostic accuracy, sensitivity, speciﬁcity, PPV,
and NPV were calculated as simple proportions with
Wald-type 95% conﬁdence intervals (CIs). The Fisher
exact test was used for comparison of FFRCT diag-
nostic accuracy, sensitivity, and speciﬁcity across
TABLE 3 Proportion of Patients (N ¼ 214) with a Positive Test Result (Coronary CTA,
FFRCT, and FFR) According to Quartile of Agatston Scores
Agatston Score
Q1
(range 0–26)
Q2
(range 27–147)
Q3
(range 148–415)
Q4
(range 416–3,599)
Coronary CTA
stenosis >50%
39 (72) 40 (74) 34 (64) 45 (85)
FFRCT #0.80 19 (35) 16 (30) 21 (40) 26 (49)
FFR #0.80 13 (24) 13 (24) 18 (34) 16 (30)
Values are n (%). A positive test result was deﬁned as lumen reduction >50% for coronary CTA and FFRCT or
FFR #0.80, respectively.
Q ¼ quartile; other abbreviations as in Table 2.
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1048AS quartiles. Subject-level comparison of diagnostic
performance characteristics was performed by using
the McNemar test for paired samples or the percentile
bootstrap approach with 100,000 resamples as
appropriate. Pearson’s correlation coefﬁcient was
calculated for assessment of the per-vessel relation-
ship of FFRCT and FFR. Bland-Altman plots weretic Performance Characteristics of FFRCT With Increasing
els
racy Sensitivity Specificity
62.0=p54. p = 0.76
Agatston score
Q1 (0 - 26)
Q2 (27-147)
Q3 (148 - 415)
Q4 (416 - 3599)
Agatston score
Q1 (0 - 0)
Q2 (0 - 22)
Q3 (23 -120)
Q4 (121-1703)
.52 p = 0.33 p = 0.41
racy Sensitivity Specificity
ts (N ¼ 214) and (B) vessels (N ¼ 333) according to quartile of
g fractional ﬂow reserve #0.80 as the reference standard. The
sons of fractional ﬂow reserve derived from coronary computed
aphy (FFRCT) diagnostic accuracy, sensitivity, and speciﬁcity,
Agatston score quartiles (Q) are shown.created comparing per-vessel FFRCT and FFR values.
Conﬁdence limits were created assuming a para-
metric distribution, and 1-sample t tests were run to
detect any signiﬁcant ﬁxed bias. All analyses were
performed by using SAS version 9.3 (SAS Institute,
Inc., Cary, North Carolina).
RESULTS
PATIENT CHARACTERISTICS. Of the 254 patients
included in the NXT trial, 214 (84%) patients under-
went coronary calcium scoring and thus formed the
basis of the present study. Baseline characteristics of
the study population are presented in Table 1. The
present study cohort did not differ signiﬁcantly from
the overall NXT trial population. Per-vessel AS was
available in 163 patients (FFR examination was per-
formed in 333 vessels). The per-patient and per-vessel
characteristics of coronary CTA, ICA, FFRCT, and FFR
are shown in Table 2. Per-patient and per-vessel AS
was 302  468 (range 0 to 3,599) and 95  172 (range
0 to 1,703), respectively. The per-patient median AS
in Q1, Q2, Q3, and Q4 was 0.5 (range 0 to 26), 63 (range
27 to 147), 259 (range 148 to 415), and 711 (range 416
to 3,599). AS was >1,000 in 13 (6%) patients. The
per-vessel median AS in Q1, Q2, Q3, and Q4 was
0 (range 0 to 0), 9 (range 0 to 22), 56 (range 23 to 120),
and 248 (range 121 to 1,703). The proportion of
patients with a positive test (coronary CTA, FFRCT,
and FFR) result across AS quartiles is shown in
Table 3.
DIAGNOSTIC PERFORMANCE OF FFRCT. There was
no statistically signiﬁcant difference in per-patient or
per-vessel diagnostic accuracy, sensitivity, and
speciﬁcity of FFRCT across AS quartiles (Figure 1).
There was no difference in discrimination of ischemia
by FFRCT in patients with a high AS (416 to 3,599)
compared with those with a low-mid AS (0 to 415)
(AUC: 0.86 [95% CI: 0.76 to 0.96] vs. 0.92 [95% CI:
0.88 to 0.96]; p ¼ 0.45) (Figure 2A). Similarly, there
was no difference in discrimination of ischemia ac-
cording to FFRCT in vessels with a high AS (121 to
1,703) versus those with a low-mid AS (0 to 120) (AUC:
0.91 [95% CI: 0.85 to 0.97] vs. 0.95 [95% CI: 0.91 to
0.98]; p ¼ 0.65) (Figure 2B). Figure 3 displays a
representative case of a patient with severe calciﬁed
coronary lesions that did not cause ischemia.
DIAGNOSTIC PERFORMANCE OF FFRCT VERSUS
CORONARY CTA FOR ISCHEMIA AT VARIOUS
LEVELS OF CALCIFICATION. Accuracy, sensitivity,
speciﬁcity, NPV, and PPV for FFRCT and coronary CTA
in patients and vessels according to quartile of AS are
shown in Table 4. The per-patient and per-vessel
diagnostic accuracy and speciﬁcity of FFRCT were
FIGURE 2 AUC of Coronary CTA and FFRCT for Discrimination of Ischemia in Patients and Vessels With Low-Mid and High AS Levels
BA
0.00
0.25
0.50
0.75
1.00
Se
ns
iti
vi
ty
Se
ns
iti
vi
ty
00.157.005.052.000.000.157.005.052.000.0
0.00
0.25
0.50
0.75
1.00
yticificepS-1yticificepS-1
Low-mid AS, FFR : AUC (95% CI), 0.92 (0.88 - 0.96)
High AS, FFR : AUC (95% CI), 0.86 (0.76 - 0.96)
p = 0.45
Low-mid AS, CTA: AUC (95% CI), 0.82 (0.74 - 0.89)
High AS, CTA: AUC (95% CI), 0.72 (0.58 - 0.87)
p = 0.13
Low-mid AS, FFR : AUC (95% CI), 0.95 (0.91 - 0.98)
High AS, FFR : AUC (95% CI), 0.91 (0.85 - 0.97)
p = 0.65
Low-mid AS, CTA: AUC (95% CI), 0.85 (0.78 - 0.92)
High AS, CTA: AUC (95% CI), 0.71 (0.57 - 0.85)
p = 0.01
Discrimination of ischemia by FFRCT (#0.80) and coronary computed tomography angiography (CTA) (lumen reduction >50%) in (A) patients
with a low-mid (0 to 415; n ¼ 161) or high (416 to 3,599; n ¼ 53) Agatston score (AS); and (B) vessels with a low-mid (0 to 120; n ¼ 250)
or a high (121 to 1,703; n ¼ 83) AS using fractional ﬂow reserve (FFR) #0.80 as the reference standard. FFRCT versus coronary CTA area under
the receiver-operating characteristic curve (AUC) comparisons in patients with a low-mid or high AS, and vessels with low-mid or high AS,
revealed p values of 0.004, 0.09, 0.002, and 0.004, respectively. CI ¼ conﬁdence interval; other abbreviation in Figure 1.
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1049higher than for coronary CTA in each AS quartile, with
similar high sensitivity. In patients with a low-mid or
high AS, FFRCT correctly reclassiﬁed 74% and 60% of
coronary CTA false-positive to true-negative ﬁndings,
whereas in vessels, the proportion was 70% regard-
less of the AS level (Figure 4). FFRCT displayed
improved discrimination of ischemia in highly calci-
ﬁed vessels compared with coronary CTA alone (AUC:
0.91 vs. 0.71; p ¼ 0.004); on a per-patient level, the
difference did not reach statistical signiﬁcance (AUC:
0.86 vs. 0.72; p ¼ 0.09) (Figure 2).
CORRELATION OF FFRCT TO FFR. There was a good
correlation of FFRCT to FFR in vessels with a low-mid
AS (0 to 120) or high AS (121 to 1,703) with R values of
0.82 (p < 0.0001) and 0.79 (p < 0.0001), respectively
(Figures 5A to 5C). The difference between FFR and
FFRCT values in vessels with a low-mid AS was 0.03 
0.07 (95% limits of agreement: 0.10 to 0.17) and 0.01
 0.08 (95% limits of agreement: 0.14 to 0.16) in
vessels with a high AS (Figures 5D and 5E).DISCUSSION
The present study examined the diagnostic perfor-
mance of FFRCT at various levels of coronary calciﬁ-
cation for the identiﬁcation and exclusion of
ischemia-causing lesions using FFR as the reference
standard. The 2 major ﬁndings of this study were:
1) FFRCT provided high per-patient and per-vessel
diagnostic performance and discrimination for
ischemia over a wide range of coronary calciﬁcation
severity; and 2) the diagnostic performance of FFRCT
was superior to coronary CTA stenosis interpretation
regardless of the AS level.
Because the presence of myocardial ischemia is
associated with a poor prognosis (23), current
guidelines recommend noninvasive functional imag-
ing testing as the ﬁrst-line strategy in patients with
suspected stable CAD (21). However, shortcomings
of current noninvasive diagnostic strategies are
apparent from the frequent inaccurate selection of
FIGURE 3 Representative Example of a Patient With High Coronary Calciﬁcation
A 65-year-old male with atypical chest pain. (A) Coronary CTA shows severe calciﬁcation of the left anterior descending artery (LAD) with a
total AS of 739. (B) Magniﬁed view of coronary CTA showing 70% to 90% stenosis of the LAD and borderline stenosis of the ﬁrst diagonal
branch. (C) Computational FFRCT analysis indicates that the LAD lesions are not hemodynamically signiﬁcant, with FFRCT in the LAD of
0.87 and in the diagonal branch, 0.91. (D) Quantitative coronary angiography demonstrates maximal stenosis of 52% in the ﬁrst diagonal
branch (red arrow). The stenosis was not hemodynamically signiﬁcant, with FFR in the LAD of 0.84 and in the diagonal branch, 0.87. All
coronary CTA, invasive angiography, FFR, and FFRCT readings were performed in a blinded fashion. Abbreviations as in Figures 1 and 2.
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1050patients for ICA (24,25). To date, FFR is the only
diagnostic tool shown to improve clinical outcomes
and to reduce health care costs in large prospective
randomized trials (26,27). As a result, FFR is consid-
ered the gold standard for guiding coronary revas-
cularization (28). The use of FFR, however, is
inherently limited by its invasiveness and costs.
Moreover, FFR cannot always be measured in vessels
due to extreme vessel tortuosity and/or coronary
calciﬁcation. These issues underscore the need for
more diagnostically accurate noninvasive testing
modalities for gatekeeping to the catheterization
laboratory.
In the present study, we considered high levels of
coronary calciﬁcation to be represented by patients
and vessels in the fourth quartile of AS values.An AS threshold of 400 has previously been used to
differentiate cardiovascular risk independent of
other risk factors (29,30), thus underscoring the
relevance in this study of a per-patient AS level of
415 as a surrogate of severe coronary calciﬁcation.
However, the presence of calciﬁcation challenges the
diagnostic performance of coronary CTA because of
limited spatial resolution with partial volume and
beam-hardening related artifacts. Accordingly, sev-
eral studies have shown that increasing severity of
coronary calciﬁcation is associated with lower diag-
nostic speciﬁcity of coronary CTA (1–8). Yan et al. (5)
recently showed that a per-patient AS $1 is an in-
dependent predictor of a false-positive coronary CTA
result. Moreover, Dewey et al. (6) found that on a
per-vessel basis, for each increase of 10 AS units, the
TABLE 4 Diagnostic Performance Characteristics of FFRCT and Coronary CTA in Patients and Vessels According to Quartile of Agatston Scores
Agatston Score
Q1 Q2 Q3 Q4
FFRCT CTA p Value FFRCT CTA p Value FFRCT CTA p Value FFRCT CTA p Value
Per patient
Accuracy 85 (73–93) 52 (38–66) 0.0004 83 (71–92) 50 (36–64) 0.0002 83 (70–92) 55 (40–68) 0.0006 74 (60–85) 42 (28–56) 0.0007
Sensitivity 92 (64–100) 100 (75–100) 0.32 77 (46–95) 100 (75–100) 0.66 83 (59–96) 78 (52–94) 0.32 88 (62–98) 94 (70–100) 0.32
Speciﬁcity 83 (68–93) 37 (22–53) 0.0001 85 (71–94) 34 (20–51) <0.0001 83 (66–93) 43 (26–61) 0.0002 68 (50–82) 19 (8–35) 0.0002
PPV 63 (38–84) 33 (19–50) 0.01 63 (35–85) 33 (19–49) 0.02 71 (48–89) 41 (25–59) 0.01 54 (33–73) 33 (20–49) 0.04
NPV 97 (85–100) 100 (78–100) 0.64 92 (79–98) 100 (77–100) 0.95 91 (75–98) 79 (54–94) 0.14 93 (76–99) 88 (47–100) 0.37
Per vessel
Accuracy 90 (83–95) 74 (65–82) 0.001 85 (74–93) 71 (59–82) 0.03 88 (79–94) 60 (49–71) <0.0001 83 (73–91) 55 (44–66) <0.0001
Sensitivity 73 (39–94) 91 (59–100) 0.16 67 (35–90) 92 (62–100) 0.16 93 (68–100) 80 (52–96) 0.16 82 (60–95) 82 (60–95) 1.00
Speciﬁcity 92 (85–97) 72 (62–81) 0.0001 89 (77–96) 67 (53–79) 0.001 87 (76–94) 56 (43–68) <0.0001 84 (72–92) 46 (33–59) <0.0001
PPV 53 (27–79) 29 (15–46) 0.06 57 (29–82) 38 (21–58) 0.13 61 (39–80) 29 (16–45) 0.005 64 (44–81) 35 (22–50) 0.0008
NPV 97 (90–99) 99 (92–100) 0.77 92 (82–98) 97 (86–100) 0.87 98 (91–100) 93 (80–99) 0.08 93 (82–98) 88 (72–98) 0.22
Values are proportions (%) with 95% conﬁdence intervals shown in parentheses. The per-patient analysis was performed in 214 patients and the per-vessel analysis in 163 patients (333 vessels).
The per-patient and per-vessel AS ranges for Q1 were 0 to 26 and 0 to 0, respectively; for Q2, 27 to 147 and 0 to 22, respectively; for Q3, 148 to 415 and 23 to 120, respectively; and for Q4, 416 to 3,599 and
121 to 1,703, respectively. A positive test result was deﬁned as lumen reduction >50% for coronary CTA and FFRCT #0.80, respectively. FFR #0.80 was diagnostic of lesion-speciﬁc ischemia.
NPV ¼ negative predictive value; PPV ¼ positive predictive value; other abbreviations as in Table 2.
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1051risk of a misdiagnosis increased by 3%. Thus,
guidelines do not recommend performing coronary
CTA in patients with high levels of coronary calciﬁ-
cation (21).FIGURE 4 Consequences of Sequential Use of Coronary CTA and FFR
A
Patients
n = 214
Low-mid AS
n = 161
High AS
n = 53
Coronary CTA
Assessment*
TP, n = 40
TN, n = 44
FP, n = 73
FN, n = 4
Coronary CTA
Assessment*
TP, n = 15
TN, n = 7
FP, n = 30
FN, n = 1
FFR  Assessment†
TP, n = 37
TN, n = 98
FP, n = 19
FN, n = 7
FFR  Assessment†
TP, n = 14
TN, n = 25
FP, n = 12
FN, n = 2
Coronary CTA and FFRCT true-positives (TP), true-negatives (TN), false-p
AS (0 to 415) or a high AS (416 to 3,599); and (B) vessels with a low-m
(#0.80) as the reference standard. Values shown represent numbers of
†FFR #0.80. Abbreviations as in Figures 1 and 2.In 3 previous prospective multicenter trials
including a total of 609 patients and 1,050 vessels
with blinded comparison to FFR, computation of
FFRCT from standard acquired coronary CTA imagesCT on Diagnostic Performance Characteristics
B
Low-mid AS
n = 250
High AS
n = 83
Vessels
n = 333
Coronary CTA
Assessment*
TP, n = 33
TN, n = 139
FP, n = 73
FN, n = 5
Coronary CTA
Assessment*
TP, n = 18
TN, n = 28
FP, n = 33
FN, n = 4
FFR  Assessment†
TP, n = 30
TN, n = 190
FP, n = 22
FN, n = 8
FFR  Assessment†
TP, n = 18
TN, n = 51
FP, n = 10
FN, n = 4
ositives (FP), and false-negatives (FN) in (A) patients with a low-mid
id AS (0 to 120) or a high AS (121 to 1,703), respectively, using FFR
patients or vessels in each group. *Lumen reduction >50%.
FIGURE 5 Correlation and Bland-Altman Plots of FFR and FFRCT in Vessels With Low-Mid or High Agatston Score Levels
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(A to C) Per-vessel correlation and (D to F) Bland-Altman plots of FFRCT versus FFR. Correlation for (A) all vessels (N ¼ 333), (B) for vessels with a low-mid AS (0 to 120;
n ¼ 250), and (C) for a high AS (121 to 1,703; n ¼ 83). Bland-Altman plots for: (D) all vessels, (E) for vessels with low-mid AS, and (F) for highly calciﬁed vessels.
Abbreviations as in Figures 1 and 2.
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1052produced promising results in identifying lesion-
speciﬁc ischemia (10–12). Because FFRCT is derived
from coronary CTA images, signiﬁcant computed to-
mography imaging artifacts may impair the diag-
nostic performance of FFRCT. Thus, in the recent
NXT trial, 12% of the patients were not eligiblefor FFRCT computation because of the presence
of computed tomography–related artifacts (motion/
misregistration, high image noise, excessive calcium
blooming, or low contrast to noise), which alone or in
combination signiﬁcantly compromised the image
quality (12). However, similar to coronary CTA, the
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1053diagnostic performance of FFRCT has been shown
to improve with the adherence to best practices
guidelines for image acquisition, particularly re-
garding heart rate control and the use of pre-scan
nitroglycerin (17,31,32).
In the present study, there was a tendency towards
declining diagnostic accuracy and speciﬁcity with
increasing AS levels. However, even in the highest
quartile, with per-patient AS ranging from 416 to
3,599, FFRCT had almost a 2-fold improvement in
diagnostic accuracy and a >3-fold improvement in
speciﬁcity compared with coronary CTA interpreta-
tion alone. Accordingly, FFRCT reclassiﬁed 60% of
those patients in the highest AS quartile with false-
positive coronary CTA results to true-negative ﬁnd-
ings. Moreover, FFRCT per-patient and per-vessel
diagnostic accuracy (74% and 83%, respectively),
sensitivity (88% and 82%), and speciﬁcity (68% and
84%) in the highest AS quartile were equal to or su-
perior to diagnostic performance characteristics re-
ported for most conventional noninvasive ischemia
testing modalities when compared with directly
measured FFR (33).
The high diagnostic performance of FFRCT in
the setting of coronary calciﬁcation most likely is a
result of the FFRCT computation process. The latter
is based on a large pool of data, including the global
coronary and myocardial anatomy. Moreover,
luminal dimensions are assessed along the entire
length of each vessel by using segmentation methods
that correct for calcium blooming and physiological
models that incorporate both global and local ﬂow
factors, which may inﬂuence pressure gradients
along the course of the vessel. Thus, segmental ar-
tifacts per se may not signiﬁcantly inﬂuence the
overall FFRCT computation result. In contrast, coro-
nary CTA stenosis assessment relies on identiﬁcation
of segmental reductions in lumen caliber and, thus,
the presence of calciﬁcation may have greater impact
on interpretation and may compromise both the per-
vessel and per-patient diagnostic performance. This
is supported by ﬁndings in a substudy from the
DISCOVER-FLOW (Diagnosis of Ischemia-Causing
Coronary Stenoses by Noninvasive Fractional Flow
Reserve Computed From Coronary Computed
Tomographic Angiograms) trial, which showed that
even at lower levels of coronary CTA image quality,
FFRCT continued to provide signiﬁcant diagnostic
improvement when compared with coronary CTA
(34). Speciﬁcally, the diagnostic accuracy of FFRCT in
42 patients with calciﬁcation-related artifacts was
superior to coronary CTA (86% vs. 67%) arising from
an increase in speciﬁcity (82% vs. 29%) and compa-
rable sensitivity.The present study extends earlier ﬁndings by
demonstrating high and superior diagnostic perfor-
mance of FFRCT compared with coronary CTA inter-
pretation over a wide range of coronary calciﬁcation
severities in a large cohort of patients (and vessels).
The ﬁndings in this study support the potential of
FFRCT as a reliable gatekeeper to ICA and coronary
revascularization across a representative cohort of
patients. Moreover, the high diagnostic performance
of FFRCT in patients with coronary calciﬁcation,
together with future improvements in computed
tomography spatial resolution and/or FFRCT tech-
nology, may potentially expand the eligibility of
coronary CTA testing to patients with higher pre-test
probability of disease. Supportive of this possibility is
recent data from Pontone et al. (7) showing that high
spatial resolution compared with standard coronary
CTA is associated with improved evaluability and
diagnostic performance regardless of calciﬁcation
severity. The latter issues need further delineation in
future studies.
STUDY LIMITATIONS. The present trial was a sub-
study of the prospective, multicenter NXT trial.
Inherently, study inclusion was based on pre-speciﬁed
selection criteria (12); for example, a target heart
rate <60 beats/min and body mass index <35 kg/m2.
Furthermore, patients with recent myocardial infarc-
tion, acute coronary syndrome, or previous coronary
revascularization with percutaneous coronary inter-
vention or coronary artery bypass grafting were not
included in this study; hence, the ﬁndings cannot be
generalized to all patients with known CAD. Assess-
ment of AS was not required in the NXT study. None-
theless, AS was recorded and available in 214 (84%)
patients and in 333 vessels, representing a large pa-
tient and vessel sample size with a broad range of AS
values. The number of patients with an AS $1,000 was
very low; thus, the diagnostic performance of FFRCT
in this patient category needs further investigation.
CONCLUSIONS
FFRCT provided high diagnostic performance and
discrimination of ischemia in patients and vessels
over a wide range of coronary calciﬁcation scores. The
diagnostic accuracy and speciﬁcity of FFRCT was su-
perior to coronary CTA assessment in patients and
vessels with low, intermediate, or high levels of
calciﬁcation.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Bjarne Linde Nørgaard, Department of Cardiology,
Aarhus University Hospital Skejby, Skejby DK-8200
Aarhus N, Denmark. E-mail: bnorgaard@dadlnet.dk.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Nonin-
vasive FFRCT provided high diagnostic performance and
discrimination of ischemia in patients and vessels over a
wide range of calciﬁcation scores. The diagnostic accuracy
and speciﬁcity of FFRCT was superior to conventional cor-
onary CTA assessment in patients and vessels with low-
mid or high levels of coronary calciﬁcation.
TRANSLATIONAL OUTLOOK: The high diagnostic
performance of FFRCT in patients with coronary calciﬁ-
cation together with future improvements in computed
tomography spatial resolution and FFRCT technology may
potentially expand the eligibility of coronary CTA testing
in real-world practice (e.g., to patients with high pre-test
probability of CAD). Additional studies are needed.
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